Solventum Corporation (SOLV) Revenue History
Annual and quarterly revenue from 2021 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
SOLV Revenue Growth
Revenue Breakdown (FY 2025)
SOLV's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
By Geography
SOLV Revenue Analysis (2021–2025)
As of May 8, 2026, Solventum Corporation (SOLV) generated trailing twelve-month (TTM) revenue of $8.26 billion, reflecting slight decline in growth of -3.0% year-over-year. The most recent quarter (Q1 2026) recorded $2.01 billion in revenue, up 0.5% sequentially.
Looking at the longer-term picture, SOLV's historical revenue data shows a 3-year CAGR of +0.8%. The company achieved its highest annual revenue of $8.32 billion in 2025, representing a new all-time high.
Revenue diversification analysis shows SOLV's business is primarily driven by Product (100%). With over half of revenue concentrated in Product, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including BAX (+5.1% YoY), BDX (+2.4% YoY), and COO (+5.7% YoY), SOLV has underperformed the peer group in terms of revenue growth. Compare SOLV vs BAX →
SOLV Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| SOLVCurrent | $8.3B | -3.0% | - | 26.2% | |
 BAX | $11.2B | +5.1% | -0.7% | -2.7% | |
 BDX | $21.8B | +2.4% | +6.3% | 11.8% | |
 COO | $4.1B | +5.7% | +11.0% | 16.7% | |
 HOLX | $4.1B | +2.2% | +1.7% | 17.4% | |
 ICU | $135,000 | +1195.6% | - | -13216.3% |
SOLV Historical Revenue Data (2021–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $8.32B | +0.9% | $4.45B | 53.5% | $2.18B | 26.2% |
| 2024 | $8.25B | +0.7% | $4.59B | 55.6% | $1.04B | 12.6% |
| 2023 | $8.20B | +0.8% | $4.69B | 57.3% | $1.69B | 20.6% |
| 2022 | $8.13B | -0.5% | $4.70B | 57.7% | $1.69B | 20.8% |
| 2021 | $8.17B | - | $4.92B | 60.2% | $1.88B | 23.0% |
Full SOLV Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
See SOLV's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs SOLV Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare SOLV vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonSOLV — Frequently Asked Questions
Quick answers to the most common questions about buying SOLV stock.
Is SOLV's revenue growth accelerating or slowing?
SOLV revenue growth slowed to -3.0%, below the 5-year CAGR of N/A. TTM revenue is $8.3B. The deceleration marks a shift from historical growth rates.
What is SOLV's long-term revenue growth rate?
Solventum Corporation's 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of -3.0% is near this long-term average.
How is SOLV's revenue distributed by segment?
SOLV reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2021-2025 are available for download. Segment mix reveals concentration and diversification trends.